# Ovintiv Inc.: financial statements, quarterly

OVV · NYSE · CIK 1792580 · [Energy](/sectors/energy.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/ovv.md) · [Financials](/companies/ovv/financials.md) · [Filings](/companies/ovv/filings.md) · [Insiders](/companies/ovv/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/ovv/financials.md?period=annual).

## Income statement

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [2,913](/filings/0000950170-24-123514.md) | [2,804 d](/filings/0001193125-26-064309.md) | [2,387](/filings/0000950170-25-064603.md) | [2,193](/filings/0000950170-25-098401.md) | [2,178](/filings/0001193125-25-264977.md) | [2,185 d](/filings/0001193125-26-064309.md) | [2,375](/filings/0001193125-26-217087.md) | [2,214](/filings/0001193125-26-314501.md) | [2,020](/filings/0001193125-25-264977.md) | [2,054 d](/filings/0001193125-26-064309.md) | [2,577](/filings/0001193125-26-217087.md) | [2,872](/filings/0001193125-26-314501.md) |
| Operating income | $m | [467](/filings/0000950170-24-123514.md) | [1,188 d](/filings/0001193125-26-064309.md) | [494](/filings/0000950170-25-064603.md) | [556](/filings/0000950170-25-098401.md) | [527](/filings/0001193125-25-264977.md) | [2.0 d](/filings/0001193125-26-064309.md) | [(89.0)](/filings/0001193125-26-217087.md) | [511](/filings/0001193125-26-314501.md) | [273](/filings/0001193125-25-264977.md) | [436 d](/filings/0001193125-26-064309.md) | [(754)](/filings/0001193125-26-217087.md) | [994](/filings/0001193125-26-314501.md) |
| Interest expense | $m | [98.0](/filings/0000950170-24-123514.md) | [106 d](/filings/0001193125-26-064309.md) | [98.0](/filings/0000950170-25-064603.md) | [105](/filings/0000950170-25-098401.md) | [103](/filings/0001193125-25-264977.md) | [106 d](/filings/0001193125-26-064309.md) | [97.0](/filings/0001193125-26-217087.md) | [95.0](/filings/0001193125-26-314501.md) | [91.0](/filings/0001193125-25-264977.md) | [93.0 d](/filings/0001193125-26-064309.md) | [104](/filings/0001193125-26-217087.md) | [100](/filings/0001193125-26-314501.md) |
| Income tax | $m | [(13.0)](/filings/0000950170-24-123514.md) | [211 d](/filings/0001193125-26-064309.md) | [90.0](/filings/0000950170-25-064603.md) | [126](/filings/0000950170-25-098401.md) | [51.0](/filings/0001193125-25-264977.md) | [(41.0) d](/filings/0001193125-26-064309.md) | [(34.0)](/filings/0001193125-26-217087.md) | [92.0](/filings/0001193125-26-314501.md) | [44.0](/filings/0001193125-25-264977.md) | [(574) d](/filings/0001193125-26-064309.md) | [(197)](/filings/0001193125-26-217087.md) | [83.0](/filings/0001193125-26-314501.md) |
| Net income | $m | [406](/filings/0000950170-24-123514.md) | [856 d](/filings/0001193125-26-064309.md) | [338](/filings/0000950170-25-064603.md) | [340](/filings/0000950170-25-098401.md) | [507](/filings/0001193125-25-264977.md) | [(60.0) d](/filings/0001193125-26-064309.md) | [(159)](/filings/0001193125-26-217087.md) | [307](/filings/0001193125-26-314501.md) | [148](/filings/0001193125-25-264977.md) | [946 d](/filings/0001193125-26-064309.md) | [(630)](/filings/0001193125-26-217087.md) | [456](/filings/0001193125-26-314501.md) |
| Diluted EPS | $ per share | [1.47](/filings/0000950170-24-123514.md) | not reported | [1.24](/filings/0000950170-25-064603.md) | [1.27](/filings/0000950170-25-098401.md) | [1.92](/filings/0001193125-25-264977.md) | not reported | [(0.61)](/filings/0001193125-26-217087.md) | [1.18](/filings/0001193125-26-314501.md) | [0.57](/filings/0001193125-25-264977.md) | not reported | [(2.35)](/filings/0001193125-26-217087.md) | [1.62](/filings/0001193125-26-314501.md) |
| Basic EPS | $ per share | [1.48](/filings/0000950170-24-123514.md) | not reported | [1.25](/filings/0000950170-25-064603.md) | [1.28](/filings/0000950170-25-098401.md) | [1.93](/filings/0001193125-25-264977.md) | not reported | [(0.61)](/filings/0001193125-26-217087.md) | [1.19](/filings/0001193125-26-314501.md) | [0.58](/filings/0001193125-25-264977.md) | not reported | [(2.35)](/filings/0001193125-26-217087.md) | [1.63](/filings/0001193125-26-314501.md) |

- Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
- Operating income: us-gaap:OperatingIncomeLoss
- Interest expense: us-gaap:InterestExpense
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q3 FY2023 (2023-09-30) | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $bn | [0.0](/filings/0000950170-23-060397.md) | [0.0](/filings/0000950170-25-027914.md) | [0.0](/filings/0000950170-24-054736.md) | [0.0](/filings/0000950170-24-087984.md) | [0.0](/filings/0000950170-24-123514.md) | [0.0](/filings/0001193125-26-064309.md) | [0.0](/filings/0000950170-25-064603.md) | [0.0](/filings/0000950170-25-098401.md) | [0.0](/filings/0001193125-25-264977.md) | [0.0](/filings/0001193125-26-314501.md) | [0.0](/filings/0001193125-26-217087.md) | [0.7](/filings/0001193125-26-314501.md) |
| Current assets | $bn | [1.6](/filings/0000950170-23-060397.md) | [1.7](/filings/0000950170-25-027914.md) | [1.5](/filings/0000950170-24-054736.md) | [1.4](/filings/0000950170-24-087984.md) | [1.5](/filings/0000950170-24-123514.md) | [1.4](/filings/0001193125-26-064309.md) | [1.4](/filings/0000950170-25-064603.md) | [1.2](/filings/0000950170-25-098401.md) | [1.2](/filings/0001193125-25-264977.md) | [1.5](/filings/0001193125-26-314501.md) | [1.8](/filings/0001193125-26-217087.md) | [2.2](/filings/0001193125-26-314501.md) |
| Total assets | $bn | [19.9](/filings/0000950170-23-060397.md) | [20.0](/filings/0000950170-25-027914.md) | [19.8](/filings/0000950170-24-054736.md) | [19.8](/filings/0000950170-24-087984.md) | [19.9](/filings/0000950170-24-123514.md) | [19.3](/filings/0001193125-26-064309.md) | [19.6](/filings/0000950170-25-064603.md) | [19.7](/filings/0000950170-25-098401.md) | [19.4](/filings/0001193125-25-264977.md) | [20.4](/filings/0001193125-26-314501.md) | [22.3](/filings/0001193125-26-217087.md) | [19.3](/filings/0001193125-26-314501.md) |
| Current liabilities | $bn | [3.5](/filings/0000950170-23-060397.md) | [2.8](/filings/0000950170-25-027914.md) | [2.8](/filings/0000950170-24-054736.md) | [3.2](/filings/0000950170-24-087984.md) | [2.9](/filings/0000950170-24-123514.md) | [2.7](/filings/0001193125-26-064309.md) | [3.2](/filings/0000950170-25-064603.md) | [2.9](/filings/0000950170-25-098401.md) | [2.6](/filings/0001193125-25-264977.md) | [2.8](/filings/0001193125-26-314501.md) | [3.2](/filings/0001193125-26-217087.md) | [2.2](/filings/0001193125-26-314501.md) |
| Total liabilities | $bn | [10.3](/filings/0000950170-23-060397.md) | [9.6](/filings/0000950170-25-027914.md) | [9.6](/filings/0000950170-24-054736.md) | [9.5](/filings/0000950170-24-087984.md) | [9.2](/filings/0000950170-24-123514.md) | [8.9](/filings/0001193125-26-064309.md) | [9.5](/filings/0000950170-25-064603.md) | [9.4](/filings/0000950170-25-098401.md) | [9.2](/filings/0001193125-25-264977.md) | [9.2](/filings/0001193125-26-314501.md) | [10.7](/filings/0001193125-26-217087.md) | [7.8](/filings/0001193125-26-314501.md) |
| Long-term debt | $bn | [5.5](/filings/0000950170-23-060397.md) | [5.5](/filings/0000950170-25-027914.md) | [5.5](/filings/0000950170-24-054736.md) | [4.9](/filings/0000950170-24-087984.md) | [4.9](/filings/0000950170-24-123514.md) | [4.9](/filings/0001193125-26-064309.md) | [4.4](/filings/0000950170-25-064603.md) | [4.4](/filings/0000950170-25-098401.md) | [4.4](/filings/0001193125-25-264977.md) | [4.4](/filings/0001193125-26-314501.md) | [5.5](/filings/0001193125-26-217087.md) | [3.7](/filings/0001193125-26-314501.md) |
| Current portion of debt | $bn | [0.7](/filings/0000950170-23-060397.md) | [0.3](/filings/0000950170-25-027914.md) | [0.7](/filings/0000950170-24-054736.md) | [1.2](/filings/0000950170-24-087984.md) | [1.0](/filings/0000950170-24-123514.md) | [0.6](/filings/0001193125-26-064309.md) | [1.1](/filings/0000950170-25-064603.md) | [0.9](/filings/0000950170-25-098401.md) | [0.8](/filings/0001193125-25-264977.md) | [0.8](/filings/0001193125-26-314501.md) | [0.9](/filings/0001193125-26-217087.md) | [0.0](/filings/0001193125-26-314501.md) |
| Shareholders' equity | $bn | [9.6](/filings/0000950170-24-123514.md) | [10.4](/filings/0001193125-26-064309.md) | [10.3](/filings/0000950170-25-098401.md) | [10.3](/filings/0001193125-25-264977.md) | [10.7](/filings/0001193125-25-264977.md) | [10.3](/filings/0001193125-26-314501.md) | [10.1](/filings/0001193125-26-314501.md) | [10.4](/filings/0001193125-26-314501.md) | [10.2](/filings/0001193125-25-264977.md) | [11.2](/filings/0001193125-26-314501.md) | [11.6](/filings/0001193125-26-314501.md) | [11.5](/filings/0001193125-26-314501.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Current assets: us-gaap:AssetsCurrent
- Total assets: us-gaap:Assets
- Current liabilities: us-gaap:LiabilitiesCurrent
- Total liabilities: us-gaap:Liabilities
- Long-term debt: us-gaap:LongTermDebtNoncurrent
- Current portion of debt: us-gaap:LongTermDebtCurrent
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [906](/filings/0000950170-24-123514.md) | [1,362 d](/filings/0001193125-26-064309.md) | [659](/filings/0000950170-25-064603.md) | [1,020](/filings/0000950170-25-098401.md) | [1,022](/filings/0001193125-25-264977.md) | [1,020 d](/filings/0001193125-26-064309.md) | [873](/filings/0001193125-26-217087.md) | [1,013](/filings/0001193125-26-314501.md) | [812](/filings/0001193125-25-264977.md) | [954 d](/filings/0001193125-26-064309.md) | [1,056](/filings/0001193125-26-217087.md) | [1,632](/filings/0001193125-26-314501.md) |
| Capital expenditure | $m | [834](/filings/0000950170-24-123514.md) | [660 d](/filings/0001193125-26-064309.md) | [591](/filings/0000950170-25-064603.md) | [622](/filings/0000950170-25-098401.md) | [538](/filings/0001193125-25-264977.md) | [552 d](/filings/0001193125-26-064309.md) | [617](/filings/0001193125-26-217087.md) | [521](/filings/0001193125-26-314501.md) | [544](/filings/0001193125-25-264977.md) | [465 d](/filings/0001193125-26-064309.md) | [605](/filings/0001193125-26-217087.md) | [574](/filings/0001193125-26-314501.md) |
| Dividends paid | $m | [82.0](/filings/0000950170-24-123514.md) | [82.0 d](/filings/0001193125-26-064309.md) | [80.0](/filings/0000950170-25-064603.md) | [80.0](/filings/0000950170-25-098401.md) | [78.0](/filings/0001193125-25-264977.md) | [78.0 d](/filings/0001193125-26-064309.md) | [78.0](/filings/0001193125-26-217087.md) | [77.0](/filings/0001193125-26-314501.md) | [77.0](/filings/0001193125-25-264977.md) | [76.0 d](/filings/0001193125-26-064309.md) | [85.0](/filings/0001193125-26-217087.md) | [84.0](/filings/0001193125-26-314501.md) |
| Share repurchases | $m | [45.0](/filings/0000950170-24-123514.md) | [53.0 d](/filings/0001193125-26-064309.md) | [250](/filings/0000950170-25-064603.md) | [184](/filings/0000950170-25-098401.md) | [163](/filings/0001193125-25-264977.md) | [0.0 d](/filings/0001193125-26-064309.md) | [0.0](/filings/0001193125-26-217087.md) | [147](/filings/0001193125-26-314501.md) | [160](/filings/0001193125-25-264977.md) | [0.0 d](/filings/0001193125-26-064309.md) | [84.0](/filings/0001193125-26-217087.md) | [345](/filings/0001193125-26-314501.md) |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
- Dividends paid: us-gaap:PaymentsOfDividendsCommonStock
- Share repurchases: us-gaap:PaymentsForRepurchaseOfCommonStock

## Shares

| Line item | Unit | Q3 FY2022 (2022-09-30) | Q1 FY2023 (2023-03-31) | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [256](/filings/0000950170-23-060397.md) | [248](/filings/0000950170-24-054736.md) | [251](/filings/0000950170-24-087984.md) | [276](/filings/0000950170-24-123514.md) | [272](/filings/0000950170-25-064603.md) | [268](/filings/0000950170-25-098401.md) | [264](/filings/0001193125-25-264977.md) | [260](/filings/0001193125-26-217087.md) | [260](/filings/0001193125-26-314501.md) | [258](/filings/0001193125-25-264977.md) | [268](/filings/0001193125-26-217087.md) | [282](/filings/0001193125-26-314501.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 275,503,580 at 2026-07-17, from the cover of the [10-Q filed 2026-07-23](/filings/0001193125-26-314501.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:48 ET. No prices; not investment advice.